Entheon Biomedical Corp. (CSE: ENBI)
Canada
· Delayed Price · Currency is CAD 0.100
-0.005 (-4.76%)
Sep 25, 2024, 11:14 AM EDT
Entheon Biomedical Revenue
In the fiscal year ending November 30, 2023, Entheon Biomedical had annual revenue of 250.32K CAD with 31.97% growth.
Revenue
250.32K
Revenue Growth
+31.97%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
885.89K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2023 | 250.32K | 60.65K | 31.97% |
| Nov 30, 2022 | 189.68K | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | - | - | - |
| Nov 30, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries Inc. | 1.52B |
| Trulieve Cannabis Corp. | 1.59B |
| Cresco Labs Inc. | 1.01B |
| Planet 13 Holdings Inc. | 139.22M |
| Ayr Wellness Inc. | 635.84M |
| Grown Rogue International Inc. | 28.83M |
| Jushi Holdings Inc. | 360.23M |
| iAnthus Capital Holdings, Inc. | 229.29M |